We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Diatron MI Plc

Develops, manufactures and markets hematology analyzers, clinical chemistry analyzers, and associated reagents for hu... read more Featured Products: More products

Download Mobile App





Intelligent Walkaway Clinical Chemistry Analyzer Showcased at AACC

By LabMedica International staff writers
Posted on 27 Jul 2015
A global provider of hematology and clinical chemistry analyzers will display its new economic walkaway clinical chemistry analyzer at the 2015 annual meeting of the American Association of Clinical Chemistry (AACC; Washington DC, USA) in Atlanta (GA, USA) during July 28–30, 2015, in booth 2100.

The Pictus P500 by the the Diatron Group (Budapest, Hungary) is a new medium throughput system capable of 215 tests per hour on a typical sample mix is ergonomically designed and user-friendly with a high level of automation that delivers quality results. More...
Its advanced, windows-based software and smart architecture means the P500 is able to offer many features on an accessible platform. These include uninterrupted workflow, enhanced walk-away operation and remote access diagnostics, all of which have only been available on more expensive clinical chemistry systems until now.

The P500 is also user-friendly with well-structured, easy-to-service design and “one window” software featuring an easy-to-use icon interface menu and inventory management. The minimal usage of consumables and low water consumption translate to cost-effectiveness, and the P500’s proven, high quality components ensure the quality results. There is also an optional ISE module available which significantly increases the throughput to over 450 tests/hour.

Related Links:

Diatron
AACC



Gold Member
Neonatal Heel Incision Device
Tenderfoot
Online QC Software
Acusera 24•7
Rapid Sepsis Test
SeptiCyte RAPID
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image Credit: Shutterstock

New Biomarkers Predict Resistance to Targeted Therapy in Rare Blood Cancer

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive leukemia with limited treatment options and a poor prognosis. Although tagraxofusp is the first approved targeted therapy for... Read more

Immunology

view channel
Image:Proteomic tear-fluid analysis revealed abnormal patterns in proteins that regulate nerves and T cells in individuals with eye problems (Image Credit: Adobe Stock)

Diagnostic Models Detect Hidden Eye Abnormalities After Mild COVID-19

Persistent ocular symptoms after COVID-19 can severely affect reading, work, and daily tasks, yet standard eye exams often reveal no clear abnormalities. Patients experiencing photophobia, eye pain, and... Read more

Industry

view channel
Photo courtesy of Natera

Natera’s Signatera Earns IVDR Certification for Solid Tumor MRD Testing

Natera’s Signatera has received certification as a Class C device under the European Union’s In Vitro Diagnostic Regulation (IVDR), becoming the first personalized MRD test for solid tumors to achieve... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.